Management of Pemphigus With Gold Compounds
- 1 February 1976
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 112 (2) , 185-187
- https://doi.org/10.1001/archderm.1976.01630260013004
Abstract
• Fourteen of 15 patients with pemphigus have responded successfully to systemically administered gold therapy for up to four years. Eight of the 15 (56%) are in remission, requiring no therapy (mean, 21 months). The remaining seven patients are receiving maintenance systemic gold therapy. Only one instance of toxicity was seen during maintenance therapy. The high remission rate associated with gold therapy and the infrequent side-effects during maintenance therapy suggest that systemically given gold therapy may be the treatment of choice for the management of pemphigus, following initial therapy with corticosteroids when necessary. (Arch Dermatol 112:185-187, 1976)Keywords
This publication has 5 references indexed in Scilit:
- Pemphigus. Epidemiologic and survival characteristics of 59 patients, 1955-1973Archives of Dermatology, 1974
- Pemphigus treatment with azathioprine. Clinical and immunologic correlationArchives of Dermatology, 1973
- Tissue gold concentration in a rheumatoid arthritic receiving chrysotherapyArthritis & Rheumatism, 1972
- Pemphigus. A 20-year survey of experience with 70 casesArchives of Dermatology, 1971
- Effect of a gold salt on the immune responseArthritis & Rheumatism, 1967